| Previous Close | Open | Close* |
|---|---|---|
| 6.27 | 6.28 | 6.33 |
| Market Cap | Dividend Yield (Annualized) |
|---|---|
| AUD 4.707B | 0.00% |
| Day Range |
|---|
| 6.23L 6.34 H |
| 52 WEEK HIGH LOW |
|---|
| 3.9L 6.36 H |
| Last Trade | 6.33 |
|---|---|
| Change% | 0.9569 |
| 52 W H/L | 6.360/3.900 |
| EBITDA | 202.315M |
| NPAT After Abnormal Items | 110.592M |
| Equity | 1.077B |
| ROE% | 10.39% |
| Total Liabilities | 470.682M |
| Total Revenue | 1.304B |
| Cash and Cash Equivalents | 800.242M |
| Share price | 6.33 |
|---|---|
| Market Cap | 4.707B |
| Price/Gross Cash Flow | 25.29 |
| Dividend Yield Excluding Special | 0.00% |
| Ending Shares | 743.657M |
| 52-Week Range | 6.360-3.900 |
| Gross DPS (AUD) | 0 |
| Gross Dividend Yield (Annualized) | 0.00% |
| Earnings Yield | 2.460 |
| Net Tangible Asset (NTA) | 1.30 |
| P/E ratio | 40.650 |
| Sector P/E | -- |
| EPS | 14.87 |
| EV/EBITDA | 14.55 |
| Net Profit Margin (%) | 8.49% |
| Gross Cash Flows Per Share | 0.17 |
| Net Gearing | -63.90% |
| Sales Per Share | 1.75 |
| Book Value Per Share | 1.43 |
The A2 Milk Company Limited (ASX: A2M) is an infant formula company founded in New Zealand by Dr. Corran McLachlan; and has set the foundation for having a2 Milk® from cows that naturally produce only the A2 protein and no A1 protein (both being beta-casein proteins), as otherwise found. This helps avert the digestive discomfort seen owing to the presence of A1 protein. A2M thus targets to bring the A1 protein from cow directly to its consumers while the cows are not treated with growth hormones, rBST or antibiotics. The group now has commercial presence across Australia, New Zealand, USA, China and UK.
Level 10, 51 Shortland Street, AUCKLAND, ., NEW ZEALAND, 1010
| Ex-Date | Net Dividend | Frank Flag | Period End Date | Type | Payable |
|---|
| Event Type | Event Date | Event Year |
|---|---|---|
| Report (Annual) | 2023-08-28 | 2023 |
| Report (Prelim) | 2023-08-28 | 2023 |
| Report (Interim) | 2023-02-20 | 2023 |
| Issued Shares | 2022-12-02 | 2022 |